Enter your login e-mail to the account
Search
- Inhibition ALK and ROS1 in the treatment of metastatic non-small lung cancer – new treatment options and recommendations
MUDr. Lucia Denková
(1/2021, Main topic ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Effective treatment of lung adenocarcinoma with target therapy – case report
MUDr. Gabriela Chowaniecová
(5/2017, Original articles & case reports ) - The effectiveness of second-generation ALK-TKIs in advance non-small cell lung cancer
MUDr. Simona Laštíková, MUDr. Michal Urda, PhD., MUDr. Juraj Mazal, MUDr. Marek Lafférs
(6/2021, Case reports ) - Správa z Best of ASCO® Slovakia 2016
MUDr. Mária Rečková
(4/2016, Events ) - Lorlatinib in 1st line ALK-positive non-small cell lung cancer
MUDr. Lucia Denková
(4/2024, Drugs & drug classes )